BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 28756264)

  • 1. Discovery of dehydroabietic acid sulfonamide based derivatives as selective matrix metalloproteinases inactivators that inhibit cell migration and proliferation.
    Huang RZ; Liang GB; Huang XC; Zhang B; Zhou MM; Liao ZX; Wang HS
    Eur J Med Chem; 2017 Sep; 138():979-992. PubMed ID: 28756264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of 18β-glycyrrhetinic acid conjugated aminobenzothiazole derivatives as Hsp90-Cdc37 interaction disruptors that inhibit cell migration and reverse drug resistance.
    Jin L; Huang R; Huang X; Zhang B; Ji M; Wang H
    Bioorg Med Chem; 2018 May; 26(8):1759-1775. PubMed ID: 29486954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.
    Yan XQ; Wang ZC; Li Z; Wang PF; Qiu HY; Chen LW; Lu XY; Lv PC; Zhu HL
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4664-71. PubMed ID: 26346367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, Biological Evaluation, and Docking of Dihydropyrazole Sulfonamide Containing 2-hydroxyphenyl Moiety: A Series of Novel MMP-2 Inhibitors.
    Wang PF; Qiu HY; Baloch SK; Gong HB; Wang ZC; Zhu HL
    Chem Biol Drug Des; 2015 Dec; 86(6):1405-10. PubMed ID: 26061284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of dehydroabietic acid thiourea derivatives containing bisphosphonate moiety as an inducer of apoptosis.
    Huang X; Huang R; Liao Z; Pan Y; Gou S; Wang H
    Eur J Med Chem; 2016 Jan; 108():381-391. PubMed ID: 26706349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Evaluation of A New Series of Thiazole Derivatives as Potential Antitumor Agents and MMP Inhibitors.
    Kaplancikli ZA; Altıntop MD; Atli O; Sever B; Baysal M; Temel HE; Demirci F; Ozdemir A
    Anticancer Agents Med Chem; 2017; 17(5):674-681. PubMed ID: 27491937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and in vitro evaluation of novel dehydroabietic acid derivatives containing a dipeptide moiety as potential anticancer agents.
    Huang XC; Jin L; Wang M; Liang D; Chen ZF; Zhang Y; Pan YM; Wang HS
    Eur J Med Chem; 2015 Jan; 89():370-85. PubMed ID: 25462253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Battle tactics against MMP-9; discovery of novel non-hydroxamate MMP-9 inhibitors endowed with PI3K/AKT signaling attenuation and caspase 3/7 activation via Ugi bis-amide synthesis.
    Ayoup MS; Fouad MA; Abdel-Hamid H; Ramadan ES; Abu-Serie MM; Noby A; Teleb M
    Eur J Med Chem; 2020 Jan; 186():111875. PubMed ID: 31740054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pentanoic acid derivative targeting matrix metalloproteinase-2 (MMP-2) induces apoptosis in a chronic myeloid leukemia cell line.
    Mukherjee A; Adhikari N; Jha T
    Eur J Med Chem; 2017 Dec; 141():37-50. PubMed ID: 29028530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and antitumor activities of novel α-aminophosphonates dehydroabietic acid derivatives.
    Huang XC; Wang M; Pan YM; Tian XY; Wang HS; Zhang Y
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5283-9. PubMed ID: 23988357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and In Vitro Anticancer Activity of Novel Dehydroabietic Acid-Based Acylhydrazones.
    Li FY; Wang X; Duan WG; Lin GS
    Molecules; 2017 Jun; 22(7):. PubMed ID: 28661452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examination of sulfonamide-based inhibitors of MMP3 using the conditioned media of invasive glioma cells.
    Poole AT; Sitko CA; Le C; Naus CC; Hill BM; Bushnell EAC; Chen VC
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):672-681. PubMed ID: 32156166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
    Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
    Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antitumor activities of novel dipeptide derivatives derived from dehydroabietic acid.
    Huang XC; Wang M; Wang HS; Chen ZF; Zhang Y; Pan YM
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1511-8. PubMed ID: 24565905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Sulfonamide Derivatives Carrying a Biologically Active 3,4-Dimethoxyphenyl Moiety as VEGFR-2 Inhibitors.
    Ghorab MM; Alsaid MS; Nissan YM; Ashour AE; Al-Mishari AA; Kumar A; Ahmed SF
    Chem Pharm Bull (Tokyo); 2016; 64(12):1747-1754. PubMed ID: 27904083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antitumor activities of novel thiourea α-aminophosphonates from dehydroabietic acid.
    Huang XC; Wang M; Pan YM; Yao GY; Wang HS; Tian XY; Qin JK; Zhang Y
    Eur J Med Chem; 2013 Nov; 69():508-20. PubMed ID: 24095745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z; Wang ZC; Yan XQ; Wang PF; Lu XY; Chen LW; Zhu HL; Zhang HW
    Bioorg Med Chem Lett; 2015 May; 25(9):1947-51. PubMed ID: 25866240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of antitumor ursolic acid long-chain diamine derivatives as potent inhibitors of NF-κB.
    Jiang W; Huang RZ; Zhang J; Guo T; Zhang MT; Huang XC; Zhang B; Liao ZX; Sun J; Wang HS
    Bioorg Chem; 2018 Sep; 79():265-276. PubMed ID: 29778798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a diverse synthetic abietane diterpenoid library for anticancer activity.
    Xu H; Liu L; Fan X; Zhang G; Li Y; Jiang B
    Bioorg Med Chem Lett; 2017 Feb; 27(3):505-510. PubMed ID: 28011223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Click chemistry-based synthesis and anticancer activity evaluation of novel C-14 1,2,3-triazole dehydroabietic acid hybrids.
    Hou W; Luo Z; Zhang G; Cao D; Li D; Ruan H; Ruan BH; Su L; Xu H
    Eur J Med Chem; 2017 Sep; 138():1042-1052. PubMed ID: 28759877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.